XML 462 R57.htm IDEA: XBRL DOCUMENT
v3.20.4

Summary of Significant Accounting Policies - Schedule of Net Income (Loss) Per Common Share (Details) - shares | 12 Months Ended
--- | ---
Dec. 31, 2018 | Dec. 31, 2017
Antidilutive securities excluded from computation of earnings per share amount | 82,897,246 | 11,847,935
Series G Preferred Stock [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 188,791 | 98,698
Series H Preferred Stock [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 58,787,879 |
Indemnity Shares of Common Stock [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 825,000 |
Unvested and Forfeitable Restricted Stock Awards [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 6,309,876 | 6,979,596
Financing Warrants [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 3,949,018 | 1,289,172
Channel Partner Warrants [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 1,017,141 | 1,303,832
2016 Plan [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 9,405,541 | 2,176,637
Options Outside [Member] |  |
Antidilutive securities excluded from computation of earnings per share amount | 2,414,000 |

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesGPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesHPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=MVEN_IndemnitySharesOfCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=MVEN_UnvestedAndForfeitableRestrictedStockAwardsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=MVEN_FinancingWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=MVEN_ChannelPartnerWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=MVEN_TwoThousandAndSixteenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=MVEN_OptionsOutsideMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |